Varicose Veins Treatment Market Size, Share, Growth, and Industry Analysis, By Types (Injection Sclerotherapy, Endovenous Ablation, Surgical Ligation and Stripping), By Applications (Hospitals, Clinics, Ambulatory Centers) , and Regional Insights and Forecast to 2035

Varicose Veins Treatment Market Size

Global Varicose Veins Treatment Market size was valued at USD 493.72 Million in 2025 and is projected to reach USD 529.86 Million in 2026, further expanding to USD 568.64 Million in 2027 and USD 1000.65 Million by 2035. The market is expected to grow at a CAGR of 7.32% during the forecast period from 2026 to 2035. Rising cases of chronic venous disorders, increasing obesity levels, and growing aging population are supporting market demand worldwide. More than 35% of adults experience vein-related problems, while nearly 60% of patients prefer minimally invasive procedures due to lower recovery time and improved treatment comfort.

The US Varicose Veins Treatment Market is witnessing stable growth because of increasing healthcare awareness and strong adoption of advanced vascular procedures. Nearly 40% of adults in the country show symptoms related to chronic venous insufficiency, while women account for almost 65% of diagnosed cases. Minimally invasive vein procedures represent more than 70% of total treatments performed across outpatient centers and hospitals. Demand for laser ablation and injection therapies has increased by over 45% due to shorter recovery periods and rising preference for cosmetic vein correction procedures among middle-aged patients.

Key Findings

• Market Size: Global Varicose Veins Treatment Market reached USD 493.72 Million in 2025, USD 529.86 Million in 2026, and USD 1000.65 Million by 2035 at 7.32% growth.
• Growth Drivers: More than 65% patients prefer minimally invasive procedures, while obesity-related venous disorders increased by 55% and outpatient treatments expanded by 48%.
• Trends: Laser-based procedures increased by 58%, same-day treatments grew by 42%, and cosmetic vein correction demand rose by 37% globally.
• Key Players: Medtronic, AngioDynamics, Lumenis, Biolitec, Teleflex (Vascular Solutions) & more.
• Regional Insights: North America held 38% share, Europe 29%, Asia-Pacific 24%, and Middle East & Africa 9% supported by rising treatment awareness.
• Challenges: Around 32% healthcare centers face specialist shortages, 28% patients delay treatment due to costs, and recurrence affects nearly 25% patients.
• Industry Impact: Over 62% healthcare providers adopted minimally invasive systems, while outpatient procedure demand increased by 47% across vascular treatment facilities.
• Recent Developments: Advanced laser device adoption increased by 51%, AI-supported imaging usage grew by 34%, and portable vascular systems expanded by 29%.

The varicose veins treatment market is evolving rapidly because of increasing demand for advanced vascular care and cosmetic treatment solutions. More than 68% of healthcare facilities now use minimally invasive vein treatment technologies due to faster recovery and lower complication rates. Compression therapy remains widely used during early-stage treatment, with nearly 50% patient preference globally. Growing sedentary lifestyles and obesity continue increasing venous disease risks by over 55%. Outpatient vascular procedures have also expanded significantly, with same-day discharge services improving patient convenience and reducing hospitalization dependency across multiple healthcare settings.

Varicose Veins Treatment Market Trends

The varicose veins treatment market is witnessing strong growth due to the increasing number of people affected by vein-related disorders and the rising demand for minimally invasive procedures. More than 30% of adults globally experience some form of venous disease, while nearly 25% of women and around 15% of men suffer from visible varicose veins symptoms. The growing aging population is also supporting the expansion of the varicose veins treatment market, as nearly 35% of people above the age of 60 are affected by chronic venous conditions. Laser-based procedures and radiofrequency ablation treatments have gained high acceptance, with minimally invasive procedures accounting for over 60% of total treatment preference among patients.

Healthcare providers are increasingly adopting advanced imaging systems and catheter-based technologies, improving treatment accuracy by more than 40%. Compression therapy continues to remain widely used, with nearly 50% of patients preferring non-surgical management during the early stages of vein disorders. In addition, awareness campaigns related to vein health have increased patient screening rates by over 45%, helping early diagnosis and treatment adoption. The demand for outpatient procedures has also increased significantly, with more than 70% of varicose veins treatments now performed in ambulatory care settings due to faster recovery and lower hospitalization needs. Growing obesity rates and sedentary lifestyles are further contributing to the rise in venous diseases, with studies showing that overweight individuals have nearly 55% higher chances of developing varicose veins. Technological innovation, improved patient awareness, and higher preference for cosmetic vein treatments are continuously shaping the varicose veins treatment market worldwide.

Varicose Veins Treatment Market Dynamics

OPPORTUNITY

"Growing Demand for Minimally Invasive Vein Procedures"

The varicose veins treatment market is creating major opportunities through the increasing adoption of minimally invasive procedures across hospitals and specialty clinics. More than 65% of patients now prefer laser therapy and radiofrequency ablation over traditional surgical methods because of shorter recovery periods and reduced pain. Nearly 58% of healthcare professionals recommend non-surgical treatment options for moderate vein conditions due to improved patient outcomes. Patient satisfaction levels for minimally invasive procedures have crossed 80%, while complication rates have dropped by almost 35% compared to conventional surgery. The rise in cosmetic awareness among adults has further increased demand, with around 40% of younger patients seeking treatment for aesthetic improvement in addition to medical benefits.

DRIVERS

"Rising Prevalence of Chronic Venous Disorders"

The increasing prevalence of chronic venous disorders is one of the major growth drivers in the varicose veins treatment market. Studies indicate that nearly 30% to 35% of the adult population experiences vein-related conditions, while prolonged standing occupations increase varicose vein risks by more than 45%. Obesity-related vein complications have also increased significantly, with overweight individuals showing nearly 55% higher risk of developing venous insufficiency. Women remain highly affected, accounting for almost 65% of total diagnosed cases globally. The demand for early-stage diagnosis has increased by over 50% due to rising awareness regarding complications such as leg ulcers, swelling, and blood clot risks associated with untreated varicose veins.

RESTRAINTS

"Limited Access to Advanced Treatment in Developing Regions"

The varicose veins treatment market faces restraints due to limited access to advanced treatment technologies in several developing and rural regions. Nearly 40% of patients in low-income areas do not receive proper vein treatment because of inadequate healthcare infrastructure and lack of trained specialists. Awareness regarding chronic venous disease remains low, with more than 35% of patients ignoring early symptoms until complications arise. Traditional surgery is still used in many regions despite minimally invasive procedures showing almost 50% faster recovery rates. In addition, insurance coverage limitations affect treatment adoption, as around 30% of patients delay procedures because of out-of-pocket medical expenses and limited reimbursement support.

CHALLENGE

"High Procedure Costs and Risk of Treatment Recurrence"

One of the major challenges in the varicose veins treatment market is the high cost associated with advanced vein treatment procedures and the possibility of recurrence after therapy. Nearly 20% to 25% of treated patients experience recurrence of varicose veins symptoms due to lifestyle factors and underlying venous insufficiency. Follow-up care and multiple treatment sessions increase the overall healthcare burden for patients. Additionally, around 28% of patients hesitate to undergo laser or ablation procedures because of concerns related to side effects and post-treatment discomfort. Shortage of experienced vascular specialists in certain regions also impacts treatment quality, while nearly 32% of healthcare facilities face delays in adopting modern vein treatment technologies due to operational and training challenges.

Segmentation Analysis

The Global Varicose Veins Treatment Market is segmented by type and application, with increasing demand for minimally invasive procedures supporting market expansion across healthcare facilities. The Global Varicose Veins Treatment Market size was USD 493.72 Million in 2025 and is projected to reach USD 529.86 Million in 2026 and USD 1000.65 Million by 2035, exhibiting a CAGR of 7.32% during the forecast period. More than 62% of patients prefer non-surgical treatment methods because of lower pain and faster recovery. Hospitals and ambulatory centers are seeing higher patient visits due to rising obesity levels, aging population growth, and improved awareness about chronic venous disorders. Endovenous procedures account for over 55% of advanced vein therapies worldwide.

By Type

Injection Sclerotherapy

Injection sclerotherapy is widely used for treating spider veins and smaller varicose veins because of its quick treatment process and lower recovery time. Nearly 48% of cosmetic vein procedures involve sclerotherapy due to patient preference for non-surgical methods. More than 52% of vein clinics recommend this procedure for early-stage venous disorders. The treatment has shown over 75% patient satisfaction because of improved appearance and reduced swelling after therapy.

Injection Sclerotherapy held a market size of USD 177.73 Million in 2025, representing 36% of the total market share. This segment is expected to grow at a CAGR of 7.08% from 2025 to 2035 due to rising cosmetic treatment demand and increasing outpatient procedures.

Endovenous Ablation

Endovenous ablation is gaining high demand due to improved treatment precision and reduced hospitalization requirements. More than 65% of vascular specialists recommend laser and radiofrequency ablation for moderate and severe varicose veins conditions. Nearly 58% of patients prefer this treatment because of faster healing and reduced discomfort. Technological advancements in catheter systems and imaging support have improved procedural success rates by over 40%.

Endovenous Ablation accounted for USD 202.43 Million in 2025, representing 41% of the total market share. This segment is projected to expand at a CAGR of 7.60% during the forecast period because of rising preference for minimally invasive vascular procedures.

Surgical Ligation and Stripping

Surgical ligation and stripping remains important for severe and complicated venous insufficiency cases. Nearly 30% of patients with advanced vein disorders still undergo surgical treatment when laser therapies are not suitable. Hospitals continue using this method because of its effectiveness in treating damaged veins and recurring venous complications. More than 35% of public healthcare centers in developing regions still depend on conventional surgical techniques.

Surgical Ligation and Stripping represented USD 113.56 Million in 2025, accounting for 23% of the total market share. This segment is anticipated to grow at a CAGR of 6.82% due to continued demand for complex vein treatment procedures.

By Application

Hospitals

Hospitals continue to perform a high percentage of varicose veins procedures because of advanced surgical infrastructure and specialist availability. Nearly 60% of severe vein disorder cases are managed in hospitals due to access to emergency support and imaging systems. More than 68% of elderly patients prefer hospitals for combined vascular treatment and chronic disease management. Hospitals are also adopting advanced laser systems to improve patient outcomes and reduce complications.

Hospitals accounted for USD 246.86 Million in 2025, representing 50% of the total market share. This application segment is expected to grow at a CAGR of 7.18% from 2025 to 2035 because of rising vascular treatment demand and increasing patient admissions.

Clinics

Clinics are becoming increasingly popular in the varicose veins treatment market because of faster consultation services and affordable treatment options. Nearly 46% of cosmetic vein treatments are performed in specialty clinics due to shorter waiting times and personalized patient care. Demand for laser and injection procedures in clinics has increased by over 38% due to rising urban healthcare awareness and improved outpatient treatment services.

Clinics held a market size of USD 148.12 Million in 2025, accounting for 30% of the total market share. This segment is projected to grow at a CAGR of 7.40% because of increasing demand for minimally invasive cosmetic vein treatments.

Ambulatory Centers

Ambulatory centers are witnessing strong growth because of rising preference for same-day discharge and lower hospitalization time. More than 72% of minimally invasive procedures are now performed in outpatient facilities due to reduced recovery periods. Patient visits to ambulatory centers increased by nearly 42% because of lower treatment costs and faster procedure scheduling. Advanced laser systems are also improving treatment efficiency in these facilities.

Ambulatory Centers accounted for USD 98.74 Million in 2025, representing 20% of the total market share. This segment is expected to expand at a CAGR of 7.66% due to growing preference for outpatient vascular treatment services.

Varicose Veins Treatment Market Regional Outlook

The Global Varicose Veins Treatment Market is expanding across major regions due to increasing awareness regarding venous diseases, growing aging population, and rising demand for minimally invasive procedures. The Global Varicose Veins Treatment Market size was USD 493.72 Million in 2025 and is projected to reach USD 529.86 Million in 2026 and USD 1000.65 Million by 2035, growing at a CAGR of 7.32% during the forecast period. North America accounts for 38% market share, Europe represents 29%, Asia-Pacific contributes 24%, and Middle East & Africa holds 9% share. Rising obesity rates and improved healthcare infrastructure continue supporting treatment adoption globally.

North America

North America leads the varicose veins treatment market because of advanced healthcare systems and high awareness regarding chronic venous disorders. Nearly 35% of adults in the region experience symptoms related to vein diseases, while more than 65% of vascular clinics provide minimally invasive procedures. Outpatient vein treatments increased by over 48% because of faster recovery and reduced hospitalization needs. Laser ablation procedures account for nearly 58% of advanced treatments across healthcare facilities. Rising obesity levels and sedentary lifestyles continue increasing patient numbers in the region.

North America accounted for USD 201.35 Million in 2026, representing 38% of the total market share. The region continues expanding due to growing adoption of advanced vascular technologies and increasing patient awareness regarding vein health.

Europe

Europe holds a strong share in the varicose veins treatment market due to increasing aging population and improved healthcare awareness. Nearly 32% of adults experience chronic venous conditions, while women account for over 60% of diagnosed cases. Minimally invasive procedures are preferred by nearly 57% of patients because of shorter recovery time and lower complication risks. Public healthcare awareness programs have increased early diagnosis rates by more than 40%, supporting treatment growth across hospitals and specialty clinics.

Europe represented USD 153.66 Million in 2026, accounting for 29% of the total market share. Rising healthcare investments and growing use of laser-based vein treatment technologies continue supporting regional expansion.

Asia-Pacific

Asia-Pacific is witnessing rapid market growth due to increasing healthcare access, rising obesity levels, and growing awareness regarding vascular disorders. Nearly 27% of adults in urban areas experience symptoms related to venous insufficiency. Demand for minimally invasive procedures increased by over 50% because of expanding medical infrastructure and growing patient preference for outpatient treatments. Cosmetic vein procedures are also becoming more popular among younger adults in metropolitan regions across Asia-Pacific countries.

Asia-Pacific accounted for USD 127.16 Million in 2026, representing 24% of the total market share. Increasing healthcare modernization and rising patient awareness continue driving regional treatment demand.

Middle East & Africa

The Middle East & Africa varicose veins treatment market is steadily growing because of improving healthcare facilities and increasing awareness regarding venous diseases. Nearly 18% of adults in urban locations experience chronic vein-related conditions, while obesity-related complications continue increasing. Laser-based vascular treatments have seen demand growth above 30% due to rising preference for minimally invasive cosmetic procedures. Private healthcare investments are improving access to advanced vascular treatment systems across multiple countries in the region.

Middle East & Africa accounted for USD 47.69 Million in 2026, contributing 9% of the total market share. Increasing healthcare awareness and expansion of outpatient treatment services are supporting market growth across the region.

List of Key Varicose Veins Treatment Market Companies Profiled

Investment Analysis and Opportunities in Varicose Veins Treatment Market

The varicose veins treatment market is attracting increasing investments because of rising patient demand for minimally invasive vascular procedures. Nearly 63% of healthcare investors are focusing on laser-based treatment technologies and outpatient care expansion. Investments in ambulatory centers increased by more than 45% due to growing preference for same-day discharge procedures. Around 58% of vascular clinics are upgrading imaging systems and catheter-based devices to improve procedural success rates. Demand for cosmetic vein treatments among younger adults has increased by nearly 37%, creating strong opportunities for specialty clinics. More than 42% of medical device manufacturers are focusing on AI-supported vascular treatment systems to improve treatment accuracy and patient monitoring efficiency.

New Products Development

New product development in the varicose veins treatment market is increasing rapidly because of growing demand for safer and faster vascular procedures. Nearly 54% of manufacturers are developing advanced laser devices with improved precision and lower skin damage risks. Catheter-based treatment systems with flexible navigation features improved procedural efficiency by more than 40%. Portable imaging technologies are gaining popularity among ambulatory centers and specialty clinics because of faster diagnosis support. More than 46% of newly launched products focus on reducing patient discomfort and shortening recovery time. Automated vein closure systems and AI-supported imaging platforms are also improving treatment planning and healthcare workflow efficiency.

Developments

• Medtronic: Expanded minimally invasive vascular device production in 2024, improving procedural efficiency by over 35% and increasing healthcare facility adoption across multiple regions.
• AngioDynamics: Introduced upgraded laser ablation systems with enhanced imaging support, helping reduce treatment time by nearly 28% and improving patient comfort levels.
• Lumenis: Enhanced laser therapy platforms with better precision features, resulting in more than 32% improvement in vein targeting and reduced post-treatment complications.
• Teleflex (Vascular Solutions): Expanded outpatient vascular treatment support technologies, increasing ambulatory center adoption by over 30% and improving same-day discharge procedures.
• Biolitec: Improved endovenous laser treatment systems with advanced energy delivery technology, helping healthcare providers increase treatment success rates by nearly 38%.

Report Coverage

The varicose veins treatment market report provides detailed analysis of treatment types, applications, regional outlook, competitive landscape, and industry growth factors. The report evaluates market performance across hospitals, clinics, and ambulatory centers while covering procedures such as injection sclerotherapy, endovenous ablation, and surgical ligation and stripping. SWOT analysis included in the report highlights major strengths such as increasing adoption of minimally invasive procedures, which now account for over 65% of total treatments worldwide. Rising patient awareness and growing obesity-related vein disorders continue supporting market demand globally.

The report also examines weaknesses affecting market expansion, including treatment recurrence rates impacting nearly 25% of patients and specialist shortages affecting around 30% of healthcare facilities. Opportunities discussed include increasing investment in AI-supported vascular treatment systems and growing outpatient care demand, with ambulatory treatment procedures increasing by more than 40%. Threat analysis focuses on high procedure costs, limited healthcare access in rural regions, and delayed diagnosis among over 35% of patients suffering from chronic venous disorders.

The report further covers technological advancements, patient preference trends, healthcare infrastructure developments, and regulatory environments influencing the market. Regional analysis explains healthcare adoption patterns across North America, Europe, Asia-Pacific, and Middle East & Africa. More than 58% of healthcare providers are currently investing in advanced laser and imaging systems to improve treatment precision and patient satisfaction. Competitive profiling of key market participants also highlights innovation strategies, product development activities, and expansion initiatives shaping the global varicose veins treatment industry.

Future Scope

The future scope of the varicose veins treatment market remains highly positive because of increasing demand for minimally invasive procedures and growing awareness regarding vascular health. More than 70% of patients are expected to prefer non-surgical vein treatments because of lower recovery time and improved comfort levels. Advancements in laser technology and AI-supported imaging systems are likely to improve treatment accuracy by over 45%, supporting better healthcare outcomes across hospitals and ambulatory centers.

Outpatient vein treatment demand is expected to rise significantly as nearly 60% of healthcare facilities continue expanding same-day discharge services. Cosmetic vein treatment procedures among younger adults are also increasing steadily, with demand growth exceeding 35% in urban healthcare markets. Telemedicine integration and digital patient monitoring systems are likely to improve post-treatment follow-up efficiency and healthcare accessibility for patients in remote locations.

Emerging economies are expected to create strong future opportunities because of improving healthcare infrastructure and rising awareness regarding chronic venous disorders. More than 50% of private healthcare providers in developing regions are investing in advanced vascular treatment technologies. Increasing obesity rates and aging population growth will continue driving patient demand worldwide. Advanced catheter systems, portable imaging devices, and automated vein closure technologies are also expected to improve treatment success rates and reduce healthcare burden across medical facilities globally.

Varicose Veins Treatment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 493.72 Million in 2026
Market Size Value By	USD 1000.65 Million by 2035
Growth Rate	CAGR of 7.32% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Injection Sclerotherapy Endovenous Ablation Surgical Ligation and Stripping By Application : Hospitals Clinics Ambulatory Centers
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample

Frequently Asked Questions

• What value is the Varicose Veins Treatment Market expected to touch by 2035?

  The global Varicose Veins Treatment Market is expected to reach USD 1000.65 Million by 2035.

• What CAGR is the Varicose Veins Treatment Market expected to exhibit by 2035?

  The Varicose Veins Treatment Market is expected to exhibit a CAGR of 7.32% by 2035.

• Who are the top players in the Varicose Veins Treatment Market?

  Biolitec, Dornier MedTech, LSO Medical, Fosun Pharma, VVT Med, Syneron Medical, WON TECH Co., Ltd, Lumenis, Energist Group, Medtronic, El.En Group, F Care Systems, Teleflex (Vascular Solutions), AngioDynamics, Eufoton SRL

• What was the value of the Varicose Veins Treatment Market in 2025?

  In 2025, the Varicose Veins Treatment Market value stood at USD 493.72 Million.

Related Reports

Pertussis Vaccine Market Npwt Devices Market